Stem cell therapy for COVID-19: Possibilities and challenges

Pharmacology, Toxicology and Pharmaceutical Science

• Mortality Rate 100%
• Disease 50%
• Symptom 50%
• Clinical Trial 50%
• Respiratory Tract Disease 50%
• Antivirus Agent 50%
• Coronavirinae 50%
• Pandemic 50%

Keyphrases

• Emergency Use Authorization 25%
• Novel Coronavirus Infection 25%
• Critically Ill COVID-19 Patients 25%